Advertisement
Screener

Allarity Therapeutics, Inc. (ALLR) Repayments of Secured Debt

0.8 / 5 stars · 3/18 Roast Me

Allarity Therapeutics, Inc. Repayments of Secured Debt

Allarity Therapeutics, Inc. (ALLR) reported Repayments of Secured Debt of $3.70 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-08.

Discontinued › Cash Flow › Financing Activities

us-gaap:RepaymentsOfSecuredDebt · last filed 2024-03-08

  • Allarity Therapeutics, Inc. repayments of secured debt for the quarter ending 2023-12-31 was $1.01M.
  • Allarity Therapeutics, Inc. repayments of secured debt for fiscal 2023 was $3.70M.
Period endRepayments of Secured Debt 3 monthRepayments of Secured Debt 9 monthRepayments of Secured Debt 12 month
2023-12-31$1.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08
$3.70M
10-K · filed 2024-03-08
2023-09-30$2.69M
10-Q · filed 2023-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36
Lipocine Inc. (LPCN)United States$0.017B-1.79
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Rocket One Inc. (RKTO)United States$0.019B
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B